IsoPlexis Corp
DelistedCIK 1615055fmd_1938C1XMW4ZB9V803712SMSBNZManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2022, 12 periods
Latest annual · FY2022
Millions- Total revenues
- 17
- Gross profit
- (1)
- Operating income
- (101)
- Net income
- (106)
- Free cash flow
- (104)
Latest quarter · Q4 FY2022
Millions- Total revenues
- 3
- Gross profit
- (8)
- Operating income
- (32)
- Net income
- (33)
- Free cash flow
- (16)
IsoPlexis Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $16.8 million | $17.3 million | -2.9% | 10-K 2023-03-02 · proof |
| Gross profit | -$925,000 | $8.8 million | -110.6% | 10-K 2023-03-02 · proof |
| Operating income | -$101.2 million | -$76.3 million | 10-K 2023-03-02 · proof | |
| Net income | -$106 million | -$81.6 million | 10-K 2023-03-02 · proof | |
| Cash from operating activities | -$96.6 million | -$86.5 million | 10-K 2023-03-02 · proof | |
| Free cash flow | -$104 million | -$90.3 million | 10-K 2023-03-02 · proof | |
| Total assets | $109.1 million | $187.5 million | -41.8% | 10-K 2023-03-02 · proof |
| Total liabilities | $67.8 million | $45.2 million | +49.9% | 10-K 2023-03-02 · proof |
| Cash and cash equivalents | $37.5 million | $126.6 million | -70.4% | 10-K 2023-03-02 · proof |
- What was IsoPlexis Corp's revenue in fiscal 2022?
- IsoPlexis Corp reported revenue of $16.8 million for fiscal 2022 (the year ended Dec 31, 2022), against $17.3 million the year before (-2.9%). Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What was IsoPlexis Corp's gross profit in fiscal 2022?
- IsoPlexis Corp reported gross profit of -$925,000 for fiscal 2022 (the year ended Dec 31, 2022), against $8.8 million the year before (-110.6%). Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What was IsoPlexis Corp's operating income in fiscal 2022?
- IsoPlexis Corp reported operating income of -$101.2 million for fiscal 2022 (the year ended Dec 31, 2022), against -$76.3 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What was IsoPlexis Corp's net income in fiscal 2022?
- IsoPlexis Corp reported net income of -$106 million for fiscal 2022 (the year ended Dec 31, 2022), against -$81.6 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What was IsoPlexis Corp's cash from operating activities in fiscal 2022?
- IsoPlexis Corp reported cash from operating activities of -$96.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$86.5 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What was IsoPlexis Corp's free cash flow in fiscal 2022?
- IsoPlexis Corp reported free cash flow of -$104 million for fiscal 2022 (the year ended Dec 31, 2022), against -$90.3 million the year before. Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What are IsoPlexis Corp's total assets?
- As of Dec 31, 2022, IsoPlexis Corp reported total assets of $109.1 million, against $187.5 million a year earlier (-41.8%). Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What are IsoPlexis Corp's total liabilities?
- As of Dec 31, 2022, IsoPlexis Corp reported total liabilities of $67.8 million, against $45.2 million a year earlier (+49.9%). Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
- What are IsoPlexis Corp's cash and cash equivalents?
- As of Dec 31, 2022, IsoPlexis Corp reported cash and cash equivalents of $37.5 million, against $126.6 million a year earlier (-70.4%). Source: the 10-K filed with the SEC on Mar 2, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1615055&period_type=annual&limit=5"Information only, not investment advice.